Petro Matad's shares rose over 14% after its subsidiary SunSteppe Power signed a memorandum of understanding with Saudi-listed Acwa to develop a 4.5 gigawatt renewable energy project aimed at exporting electricity to China. The project would leverage Mongolia's renewable resources and proximity to China, supported by 500 megawatt-hours of battery storage. While still at the MoU stage with no final investment decision, the partnership highlights potential growth in cross-border clean energy trade. Petro Matad also has existing renewable projects totaling 570 megawatts and plans for further developments including green hydrogen and off-grid solutions for mines.
Petro Matad shares rose over 14% following news of a renewable energy partnership with Saudi-listed Acwa. For readers following energy stocks, here is Pluang's market snapshot as of Oct 19, 2026 14:31 WIB: out of 79 priced US energy stocks, 34 rose and 41 fell. Notable movers include Ovintiv Inc. (OVV) at USD 69.24 with a 3.73% increase, and Canadian Natural Resources Ltd. (CNQ) at USD 53.75 with a 3.72% increase, while Indonesia Energy Corporation Limited (INDO) declined 3.75% to USD 2.57.
Jyske Bank has repurchased shares valued at approximately DKK 2.15 billion as part of its ongoing share buyback program running from February 2026 to January 2027. The bank has acquired a total of 2,235,959 treasury shares, representing 3.84% of its ...
Jyske Bank is conducting a share buyback program from February 5, 2026, to January 29, 2027, with a maximum value of DKK 3 billion. As of mid-October 2026, the bank has repurchased shares worth approximately DKK 2.15 billion at an average price of DK...
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
